Genomics and AI in Personalized Medicine

Dr. Vijay Kumar Principal Dhanauri P G College, Haridwar, Uttarakhand EDUCATION Ph.D., Physics, Gurukul Kangri University, Haridwar, Uttarakhand (2004) M.Sc. Physics, CCS University, Meerut, Uttar Pradesh (1998) B.Sc. Physics, CCS University, Meerut, Uttar Pradesh (1996) RESEARCH AREA: Bioelectromagnetic, Recycling of waste materials National Coordinator: Asian Physics Olympiad Cell sponsored by Homi Bhabha Centre of Science, Tata Institute of Fundamental research, Department of Atomic Energy, Mumbai Dr. Kumar has more than 28 years of teaching experience at various Colleges and Universities across the country. He is serving in the Dhanauri P G College, Haridwar, Uttarakhand as a Principal. Five research scholars have been awarded with their doctorate degree under his supervision and still two students are pursuing their Ph. D. with him. He has published more than 200 research papers in SCI/Scopus-indexed and UGC-listed journals. He has also published more than 25 Indian patents. Four patents have been granted to him by the government of India. He has participated in more than 50 National and International conferences. He received five times research awards from the Graphic Era Hill University Dehradun. He has published three International and two National books. Dr. Kumar has organised more than 15 conferences and workshops as a convener in the University campus. He was the Convener of the Student Welfare Committee of the GEHU. He runs a YouTube channel called Learning Physics an Easy Way for the welfare of the students. He was the Secretary of the Indian Association of Physics Teachers, Uttarakhand Region from Jan 2019 to Dec 2024. He has become the Convener of the Asian Physics Olympiad 2022 in which 212 students from 28 countries have taken part. This event was hosted by Graphic Era Hill University Dehradun, India. He was appointed as team leader of the Indian team of the Asian Physics Olympiad 2023 and 2024 (hosted by Mongolia and Malaysia respectively) by Homi Bhabha Centre of Science Education, Tata Institute of Fundamental Research (TIFR) Department of Atomic Energy Mumbai.

Roaa Alnajjar is a Jordanian pharmacist and researcher with experience in clinical pharmacy and pharmaceutical sciences, who began her professional journey at Hashemite University in Zarqa, Jordan. She graduated with a Bachelor of Pharmacy (BPharm) from the Faculty of Pharmaceutical Sciences at Hashemite University, where she also served as a research assistant early in her career. During her time at the university, Roaa gained practical and academic experience in clinical pharmacy practice and research methodology, contributing to multi-disciplinary studies that explored contemporary pharmaceutical topics relevant to pharmacist knowledge and practice. She co-authored research investigating pharmacists’ awareness and views toward biosimilar medicines in Jordan, a study that assessed knowledge predictors and perspectives among pharmacy professionals, highlighting the evolving role of pharmacists in modern healthcare. In addition to this, Roaa participated as a co-researcher in investigations into community pharmacists’ understanding of SGLT2 inhibitors—an important class of medications used in managing type 2 diabetes mellitus—where she contributed to data curation, methodology, and analysis in a collaborative, peer-reviewed study. After her academic tenure at Hashemite University, Roaa transitioned into the pharmaceutical industry, where she currently works as a Regulatory Affairs Officer at Al-Noor Drug Store in Amman, Jordan. In this role, she applies her clinical knowledge to regulatory compliance, contributing to the safe distribution and registration of pharmaceutical products within the Jordanian market. Roaa is proficient in both Arabic and English and holds professional credentials that support her ongoing commitment to strengthening pharmacy practice and patient-centered care.

Dr. Neetu Sharma is a researcher and academician with a PhD in Blockchain Technology from Delhi Technological University (DTU), India. She has over 11 years of combined experience spanning 8 years in academia and 3+ years in industry. Her research interests include blockchain applications in healthcare, artificial intelligence, machine learning, IoT, big data analytics, image processing, and VLSI design. Dr. Sharma has published 46 research papers in reputed SCI, Scopus-indexed and other renowned journals and conferences, including Springer book series, and has guided/co-guided 16 M.Tech theses. She is a UGC-NET qualified Assistant Professor, Gold Medalist in M.Tech, and recipient of multiple honors, including the Research Excellence Awards (2024 & 2025) from DTU and the Srijan Award from the MP Council of Science and Technology. She also earns royalties from international publishers and actively contributes to research, peer review, and academic development activities.

Paul Olamide Ottu earned his Bachelor of Technology in Biochemistry with First Class Honors from Ondo State University of Science and Technology (OAUSTECH), Nigeria. His undergraduate research examined the expression of pro-inflammatory genes in STZ-induced diabetic rats treated with Hibiscus rosa-sinensis extract, providing mechanistic insight into inflammation-mediated metabolic dysfunction. This work laid the foundation for his continued interest in the molecular mechanisms underlying metabolic and neurodegenerative diseases. Prior to his PhD training, Paul served as a research assistant at Teddy Bioscience Research Laboratory, Nigeria, where he conducted gene expression analyses, molecular docking, and in silico drug discovery studies targeting cancer, diabetes, and Alzheimers disease. He has extensive experience using Schrödinger molecular modeling tools, NCBI databases, and in vivo rodent models, including intraperitoneal injections, oral gavage, and organ harvesting. Earlier, at the Nigerian Institute of Medical Research (NIMR), he contributed to large-scale public health and antimicrobial resistance projects, including SARS-CoV-2 co-infection studies and the SARMAAN azithromycin mass drug administration initiative. Paul has authored and co-authored multiple peer-reviewed publications in journals such as In Silico Pharmacology, Current Proteomics, and Informatics in Medicine Unlocked, with research spanning computational drug discovery, metabolic disease, cancer biology, and neurodegeneration. He currently serves as a peer reviewer for The Protein Journal, Scientific Reports, Discover Endocrinology and Metabolism, Discover Oncology (Springer Nature), and PLOS ONE. He has also presented his research at national and international conferences, including the Nigerian Academy of Science Annual Conference.

Aderonke Elizabeth Fakayode is a biomedical scientist and PhD researcher in Biomedical Sciences at Augusta University, USA, with a research focus on immunology, genomics, and computational biology. Her work integrates single-cell transcriptomics, CITE-seq, and T-cell receptor sequencing to investigate immune dysregulation and cellular heterogeneity in cardiovascular diseases, particularly coronary artery disease. She has strong expertise in genomics, multi-omics data integration, bioinformatics, and AI-assisted analytical workflows, with hands-on experience in large-scale single-cell data analysis, immune profiling, and precision medicine applications. Her research combines experimental biology with advanced computational approaches to uncover clinically relevant immune mechanisms. She has authored peer-reviewed publications spanning immunology, bioinformatics, and biomedical sciences and actively contributes to the academic community through peer review and scholarly collaborations. Her interdisciplinary background enables her to bridge genomics, artificial intelligence, and translational medicine, supporting the development of data-driven personalized healthcare solutions.